177 related articles for article (PubMed ID: 3623016)
1. Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver.
Francavilla A; Di Leo A; Eagon PK; Polimeno L; Guglielmi F; Fanizza G; Barone M; Starzl TE
Gastroenterology; 1987 Oct; 93(4):681-6. PubMed ID: 3623016
[TBL] [Abstract][Full Text] [Related]
2. In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay.
Armanini D; Karbowiak I; Goi A; Mantero F; Funder JW
Clin Endocrinol (Oxf); 1985 Oct; 23(4):341-7. PubMed ID: 4064345
[TBL] [Abstract][Full Text] [Related]
3. Circadian rhythm of hepatic cytosolic and nuclear estrogen and androgen receptors.
Francavilla A; Eagon PK; DiLeo A; Van Thiel DH; Panella C; Polimeno L; Amoruso C; Ingrosso M; Aquilino AM; Starzl TE
Gastroenterology; 1986 Jul; 91(1):182-8. PubMed ID: 3710067
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone and potassium canrenoate in normal man.
Ramsay L; Shelton J; Harrison I; Tidd M; Asbury M
Clin Pharmacol Ther; 1976 Aug; 20(2):167-77. PubMed ID: 780038
[TBL] [Abstract][Full Text] [Related]
5. Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.
Andriulli A; Arrigoni A; Gindro T; Karbowiak I; Buzzetti G; Armanini D
Digestion; 1989; 44(3):155-62. PubMed ID: 2697627
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor in rat liver: characterization and separation from a male-specific estrogen-binding protein.
Eagon PK; Seguiti SM; Rogerson BJ; McGuire TF; Porter LE; Seeley DH
Arch Biochem Biophys; 1989 Jan; 268(1):161-75. PubMed ID: 2783543
[TBL] [Abstract][Full Text] [Related]
7. Effects of repeated administration of potassium canrenoate (SC-14266) on serum gonadotrophin, prolactin, testosterone and progesterone in male rats.
Muraki T; Nakadate T; Kubota K; Tokunaga Y; Kato R
Experientia; 1980 Jun; 36(6):668-9. PubMed ID: 6774884
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone and canrenoate-K: relative potency at steady state.
Ramsay L; Asbury M; Shelton J; Harrison I
Clin Pharmacol Ther; 1977 May; 21(5):602-9. PubMed ID: 858213
[TBL] [Abstract][Full Text] [Related]
9. The effect of different types of hepatic injury on the estrogen and androgen receptor activity of liver.
Kahn D; Zeng Q; Kajani M; Eagon PK; Lai H; Makowka L; Starzl TE; Van Thiel DH
J Invest Surg; 1989; 2(2):125-33. PubMed ID: 2487243
[TBL] [Abstract][Full Text] [Related]
10. Modifications of the gonadal function in the adult rat after fetal exposure to spironolactone.
Jaussan V; Lemarchand-Béraud T; Gómez F
Biol Reprod; 1985 Jun; 32(5):1051-61. PubMed ID: 3926011
[TBL] [Abstract][Full Text] [Related]
11. Effects of H2-antagonists on androgen imprinting of male hepatic functions.
Turocy JF; Chiang AN; Seeley DH; Eagon PK
Endocrinology; 1985 Nov; 117(5):1953-61. PubMed ID: 3862576
[TBL] [Abstract][Full Text] [Related]
12. Antiandrogenic effect of spirolactones: mechanism of action.
Corvol P; Michaud A; Menard J; Freifeld M; Mahoudeau J
Endocrinology; 1975 Jul; 97(1):52-8. PubMed ID: 166833
[TBL] [Abstract][Full Text] [Related]
13. Difference in metabolic profile of potassium canrenoate and spironolactone in the rat: mutagenic metabolites unique to potassium canrenoate.
Cook CS; Hauswald CL; Schoenhard GL; Piper CE; Patel A; Radzialowski FM; Hribar JD; Aksamit W; Finnegan P; Bible RH
Arch Toxicol; 1988 Jan; 61(3):201-12. PubMed ID: 3355365
[TBL] [Abstract][Full Text] [Related]
14. Androgen-responsive functions of male rat liver. Effect of chronic alcohol ingestion.
Eagon PK; Willett JE; Seguiti SM; Appler ML; Gavaler JS; Van Thiel DH
Gastroenterology; 1987 Dec; 93(6):1162-9. PubMed ID: 3678734
[TBL] [Abstract][Full Text] [Related]
15. [Antiandrogenic effect of spirolactones: different mechanisms of action (author's transl)].
Mahoudeau JA; Corvol P; Valcke JC; Menard J; Bricaire H
Ann Endocrinol (Paris); 1976; 37(1):57-8. PubMed ID: 1015793
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal human liver.
Eagon PK; Francavilla A; DiLeo A; Elm MS; Gennari L; Mazzaferro V; Colella G; Van Thiel DH; Strazl TE
Dig Dis Sci; 1991 Sep; 36(9):1303-8. PubMed ID: 1654243
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of estrogen and androgen on the prostate: effects of estrogen on androgen- and estrogen-receptors, BrdU uptake, immunohistochemical study of AR, and responses to antiandrogens.
Suzuki K; Ito K; Suzuki T; Honma S; Yamanaka H
Prostate; 1995 Mar; 26(3):151-63. PubMed ID: 7534918
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone modulates androgen and oestrogen receptor content in the Sertoli cells of peripubertal rats.
Panno ML; Sisci D; Salerno M; Lanzino M; Pezzi V; Morrone EG; Mauro L; Palmero S; Fugassa E; Andò S
J Endocrinol; 1996 Jan; 148(1):43-50. PubMed ID: 8568470
[TBL] [Abstract][Full Text] [Related]
19. Spironolactone and potassium canrenoate metabolism.
Gardiner P
Lancet; 1985 Dec 21-28; 2(8469-70):1432. PubMed ID: 2867429
[No Abstract] [Full Text] [Related]
20. Spironolactone- and canrenone-induced changes in hepatic (Na+,K+)ATPase activity, surface membrane cholesterol and phospholipid, and fluorescence polarization in the rat.
Miner PB; Sneller M; Crawford SS
Hepatology; 1983; 3(4):481-8. PubMed ID: 6305816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
